Profile
Tord Labuda is Chief Executive Officer at Alzinova AB since 2024 and Independent Director at NanoEcho AB since 2023.
Formerly, Dr. Labuda was Vice President & Global Head-Clinical Development at LEO Pharma A from 2008 to 2023.
Education includes a doctorate from the University of Lund.
Tord Labuda active positions
| Companies | Position | Start |
|---|---|---|
| NANOECHO AB | Director/Board Member | 2022-12-31 |
| ALZINOVA AB | Chief Executive Officer | 2024-09-30 |
Former positions of Tord Labuda
| Companies | Position | End |
|---|---|---|
LEO Pharma A/S
LEO Pharma A/S Medical/Nursing ServicesHealth Services Provides dermatology services | Corporate Officer/Principal | 2022-12-31 |
Training of Tord Labuda
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
LEO Pharma A/S
LEO Pharma A/S Medical/Nursing ServicesHealth Services Provides dermatology services | Health Services |
University of Lund
University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alzinova AB
Alzinova AB Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provides treatment for Alzheimer’s disease | Health Technology |
Nanoecho AB
Nanoecho AB Medical SpecialtiesHealth Technology Develops medical ultrasound imaging equipment to treat rectal cancer | Health Technology |
- Stock Market
- Insiders
- Tord Labuda
















